The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Methyl (2RS,3RS)-5-oxo-2-phenyl-1-(4-sulfamoylphenyl)pyrrolidine-3-carboxylate ID: ALA4482951
PubChem CID: 155539868
Max Phase: Preclinical
Molecular Formula: C18H18N2O5S
Molecular Weight: 374.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COC(=O)[C@@H]1CC(=O)N(c2ccc(S(N)(=O)=O)cc2)[C@H]1c1ccccc1
Standard InChI: InChI=1S/C18H18N2O5S/c1-25-18(22)15-11-16(21)20(17(15)12-5-3-2-4-6-12)13-7-9-14(10-8-13)26(19,23)24/h2-10,15,17H,11H2,1H3,(H2,19,23,24)/t15-,17+/m1/s1
Standard InChI Key: GZJKGWRWCBDNPT-WBVHZDCISA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
19.6725 -7.7409 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7458 -4.0897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1680 -4.9130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7447 -4.9065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7417 -7.3469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4532 -3.6780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4377 -6.1267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1496 -7.3426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4535 -5.3182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8568 -7.7455 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
19.2606 -7.0378 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.8605 -8.5635 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1708 -4.0921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7406 -6.5341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4439 -7.7507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1446 -6.5267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0360 -6.1339 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0375 -5.3102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2550 -5.0558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7688 -5.7198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2526 -6.3895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8415 -4.3418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2492 -3.6336 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0243 -4.3429 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8397 -2.9264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9994 -7.1665 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 15 1 0
15 8 2 0
6 2 2 0
16 7 2 0
2 4 1 0
10 12 1 0
8 16 1 0
17 14 1 0
8 10 1 0
9 3 1 0
7 14 1 0
10 11 2 0
18 4 1 6
1 10 2 0
13 6 1 0
14 5 2 0
3 13 2 0
4 9 2 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 17 1 0
19 22 1 1
22 23 1 0
22 24 2 0
23 25 1 0
21 26 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.42Molecular Weight (Monoisotopic): 374.0936AlogP: 1.60#Rotatable Bonds: 4Polar Surface Area: 106.77Molecular Species: NEUTRALHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.24CX Basic pKa: ┄CX LogP: 1.22CX LogD: 1.22Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.82Np Likeness Score: -0.73
References 1. Kalinin S, Nocentini A, Kovalenko A, Sharoyko V, Bonardi A, Angeli A, Gratteri P, Tennikova TB, Supuran CT, Krasavin M.. (2019) From random to rational: A discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli-Cushman multicomponent reaction., 182 [PMID:31476557 ] [10.1016/j.ejmech.2019.111642 ]